Mutant fibrinogen A-α-chain associated with hereditary renal amyloidosis and peripheral neuropathy

Amyloid

Volumn 11, Issue 3, 2004, Pages 200-207

  De Carvalho, Mamede ^a,b   Linke, Reinhold P ^c   Domingos, Fernando ^a   Evangelista, Teresinha ^a   Ducla Soares, José Luis ^a   Nathrath, Walter B J ^d   Azevedo Coutinho, Conceição ^a   Lima, Raquel ^e   Saraiva, Maria João ^e  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d Institute of Pathology   (Germany)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Amyloidosis; Dysautonomy; Fibrinogen chain mutation; Polyneuropathy

Indexed keywords

ADENINE; AMYLOID A PROTEIN; APOLIPOPROTEIN A1; ARGININE; BETA 2 MICROGLOBULIN; FIBRINOGEN A; FIBRINOGEN VARIANT; IODINE 123; PREALBUMIN; THYMINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HAPLOTYPE; HEART INNERVATION; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; NEUROPATHY; PARASYMPATHETIC NERVE; PERIPHERAL NEUROPATHY; PORTUGAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEINURIA; SYMPTOMATOLOGY;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS, FAMILIAL; FEMALE; FIBRINOGENS, ABNORMAL; HUMANS; KIDNEY DISEASES; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; POINT MUTATION;

EID: 4744342551     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120400000772     Document Type: Article

References (28)

1. Booth DR, Tan SY, Booth SE, Hsuan JJ, Totty NF, Nguyen O, Hutton T, Vigushim DM, Tennent GA, Hutchinson WL, Thompson N, Soutar AK, Hawkins PN and Pepys MB (1995). A new apoliprotein A1 variant, Trp50Arg, causes hereditary amyloidoisis. QMJ 88, 695-702
2. Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballeria J, Sole M, Campistol JM and Pepys MB (1996). Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein Al gene. J Clin Invest 97, 2714-2721.
3. Benson MD, Liepnieks JJ, Yazaki M, Yamashita T, Hamidi Asl K, Guemther B and Kluve-Beckerman B (2001). A new hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein All gene. Genomics 15, 272-277
4. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CCF, Terry CJ, Ferst TG, Zalin AM and Hsuan JJ (1993). Human lysozyme gene mutation cause hereditary systemic amyloidosis. Nature 362, 553-557
5. Benson MD, Liepnieks JJ, Uemichi T, Whecker G and Correa R (1993). Hereditary renal amyloidosis associated with a mutant fibrinogen Aα chain. Nat Genet 3, 252-255
6. Uemichi T, Liepnieks JJ and Benson MD (1994). Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 93, 731-736
7. Uemichi T, Liepnieks JJ, Yamada T, Gertz MA, Bangs N and Benson (1996). A frame shift mutation in the fibrinogen Aα chain gene in a kindred with renal amyloidosis. Blood 87, 4197-4203
8. Hamidi L, Liepnieks JL, Uemichi T, Rebibou JM, Justrabo E, Droz D, Mousson C, Chalopin JM, Benson MD, Delpech M and Grateau G (1997). Renal amyloidosis with a frame shift mutation in fibrinogen α-chain producing a novel amyloid protein. Blood 90, 4799-4805
9. Gilmore JD, Booth DR, Rela M, Heaton ND, Rahman V, Stangou AJ, Pepys MB and Hawkins PN (2000). Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family. QJM 93, 269-275
10. Uemichi T, Liepnieks JJ, Alexander F and Benson MD (1996). The molecular basis of renal amyloidos in Irish-American and Polish-Canadian kindreds. QMJ 89, 745-750
11. Asl LH, Fournier V, Billerey C, Justrab E, Chevet D, Droz D, Pécheux C, Delpech M and Grateau G (1998). Fibrinogen Aα chain mutation (Arg554Leu) associated with hereditary renal amyloidosis in a French family. Amyloid: Int J Exp Clin Invest 5, 279-284
12. Uemichi T, Liepnieks JJ, Grotz MA and Benson MD (1998). Fibrinogen Aα chain Leu 554: an African-American kindred with late onset renal amyloidosis. Amyloid: Int J Exp Clin Invest 5, 188-192
13. Linke RP (2000). Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 436, 439-48
14. Linke RP, Hampl H, Bartl-Schwarze S and Eulitz M (1987). Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler 368, 137-144
15. Linke RP (1982). Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease. Clin Neuropathol 1, 172-182
16. Torres MF, Almeida MR and Saraiva MJM (1995). TTR exon scanning in peripheral neuropathies. Neuromusc Disord 5, 187-191
17. Ewing DJ (1978). Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med 55, 321-327
18. Ducla-Soares JL, Alves MM, de Carvalho M, Póvoa P, Conceição I and Sales-Luís ML (1994). Correlation between clinical, electromyographic and dysautonomic evolution of familial amyloidotic polyneuropathy of the Portuguese type. Acta Neurol Scand 90, 266-269
19. Ando Y, Obayashi K, Tanaka Y, Tsuji T, Uchino M, Takahashi M and Ando M (1994). Radiolabelled metaiodobenzylguanidina in assessment of autonomic dysfunction. Lancet 16, 984-985
20. Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, Isobe M and Sekigushi M (1997). Iodine-123 metaiodobenzylguanidina scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 29, 168-174
21. de Carvalho M, Moreira P, Evangelista T, Ducla-Soares JL, Bento M, Fernandes R and Saraiva MJ (2000). New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy. Muscle Nerve 23, 1016-1021
22. Saraiva MJ (2002). Sporadic cases of hereditary systemic amyloidosis. N Engl J Med 346, 1818-1819
23. Lachman HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB and Hawkins PN (2002). Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. New Engl J Med 346, 1786-1791
24. Hanyu N, Ikeda S, Nakadai A, Yanagisawa N and Powell HC (1989). Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesion. Ann Neurol 25, 340-350
25. Ikeda S, Hanyu N, Kongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N and Yokota T (1987). Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 110, 315-337
26. Stauton H (1991). Familial amyloid polineuropathies: In Vinken PJ, Bruyn GW and Klawans HL (eds) Handbook of clinical neurology, vol 60, pp. 89-115 (Amsterdam: Elsevier)
27. Linke RP (1984). Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem 32, 322-328
28. Linke RP and Nathrath WBJ (1980). Classification of amyloidoses at biopsy by the immunoperoxidase method. MMW Munch Med Wochenschr 122, 1772-1776